| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
5.92 |
% |
10.6019/CHEMBL4513141 |
| Candida albicans |
Candida albicans |
Inhibition |
21.06 |
% |
10.6019/CHEMBL4513141 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-5.43 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
Inhibition |
-12.96 |
% |
10.6019/CHEMBL4513141 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
10999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Aryl hydrocarbon receptor |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile acid receptor FXR |
IC50 |
7860.0 |
nM |
10.1016/j.bmc.2013.04.069 |
| Homo sapiens |
Bile acid receptor FXR |
Inhibition |
58.2 |
% |
10.1016/j.bmc.2013.04.069 |
| Homo sapiens |
Bile salt export pump |
AC50 |
300000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
20000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
DNA polymerase eta |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
DNA polymerase kappa |
Potency |
37685.8 |
nM |
None |
| Homo sapiens |
DNA polymerase kappa |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HEK293 |
Potency |
31.5 |
nM |
None |
| Homo sapiens |
Hepatocyte nuclear factor 4-alpha |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b02150 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-25.08 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-0.1 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
3.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Malate dehydrogenase, mitochondrial |
IC50 |
43600.0 |
nM |
10.1021/acs.jmedchem.7b01231 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
54482.7 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
68589.6 |
nM |
None |
| Homo sapiens |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 |
Potency |
89125.1 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b02150 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
12000.0 |
nM |
10.1021/acs.jmedchem.9b02150 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
FC |
22.0 |
None |
10.1021/acs.jmedchem.9b02150 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Kd |
400.0 |
nM |
10.1021/acs.jmedchem.9b02150 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1067/mcp.2002.126706 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
1800.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
9499.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
29999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
Activity |
nan |
None |
10.1124/dmd.110.035105 |
| Homo sapiens |
Pregnane X receptor |
EC50 |
11200.0 |
nM |
10.1124/dmd.110.035105 |
| Homo sapiens |
Pregnane X receptor |
EC50 |
100000.0 |
nM |
10.1124/dmd.110.035105 |
| Homo sapiens |
Pregnane X receptor |
EC50 |
nan |
None |
10.1016/j.bmc.2013.04.069 |
| Homo sapiens |
Pregnane X receptor |
Efficacy |
87.7 |
% |
10.1124/dmd.110.035105 |
| Homo sapiens |
Pregnane X receptor |
Efficacy |
105.2 |
% |
10.1124/dmd.110.035105 |
| Homo sapiens |
Pregnane X receptor |
max activation |
13.9 |
% |
10.1016/j.bmc.2013.04.069 |
| Homo sapiens |
Prelamin-A/C |
Potency |
707.9 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
8700.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Proliferating cell nuclear antigen |
IC50 |
50000.0 |
nM |
10.1016/j.bmc.2013.01.022 |
| Homo sapiens |
Rap guanine nucleotide exchange factor 3 |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Retinoid X receptor alpha |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b02150 |
| Homo sapiens |
Retinoid X receptor alpha |
EC50 |
15400.0 |
nM |
10.1021/acs.jmedchem.9b02150 |
| Homo sapiens |
Retinoid X receptor alpha |
FC |
7.4 |
None |
10.1021/acs.jmedchem.9b02150 |
| Homo sapiens |
Retinoid X receptor alpha |
Kd |
930.0 |
nM |
10.1021/acs.jmedchem.9b02150 |
| Homo sapiens |
Retinoid X receptor beta |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b02150 |
| Homo sapiens |
Retinoid X receptor gamma |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b02150 |
| Homo sapiens |
Serine/threonine-protein kinase PLK1 |
Potency |
18887.6 |
nM |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier family 22 member 1 |
Inhibition |
12.7 |
% |
10.1021/jm8003152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1A2 |
Km |
8000.0 |
nM |
10.1210/endo.142.5.8115 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Activity |
nan |
None |
10.1074/jbc.274.52.37161 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
-13.1 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Km |
3000.0 |
nM |
10.1074/jbc.274.24.17159 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Activity |
nan |
None |
10.1053/gast.2001.21176 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
11.4 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1C1 |
Km |
90.4 |
nM |
10.1210/me.2001-0309 |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
63.7 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 4A1 |
Activity |
nan |
None |
10.1210/endo.142.5.8115 |
| Homo sapiens |
Solute carrier organic anion transporter family member 4C1 |
IC50 |
8000.0 |
nM |
10.1073/pnas.0304987101 |
| Homo sapiens |
Sulfotransferase 4A1 |
Activity |
nan |
None |
None |
| Homo sapiens |
Sulfotransferase family cytosolic 1B member 1 |
Activity |
nan |
None |
None |
| Homo sapiens |
Thyroid hormone receptor |
Ratio |
1.0 |
None |
10.1021/jm00384a014 |
| Homo sapiens |
Thyroid hormone receptor alpha |
EC50 |
19.0 |
nM |
10.1021/acs.jmedchem.9b02150 |
| Homo sapiens |
Thyroid hormone receptor alpha |
FC |
139.0 |
None |
10.1021/acs.jmedchem.9b02150 |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
EC50 |
240.0 |
nM |
10.1021/acs.jmedchem.9b02150 |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
FC |
289.0 |
None |
10.1021/acs.jmedchem.9b02150 |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
10.0 |
nM |
None |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
100000.0 |
nM |
None |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
112201.8 |
nM |
None |
| Homo sapiens |
Thyroxine-binding globulin |
Activity |
100.0 |
% |
10.1021/jm00179a024 |
| Homo sapiens |
Transthyretin |
Activity |
95.0 |
% |
10.1016/j.bmcl.2009.03.004 |
| Homo sapiens |
Transthyretin |
Activity |
nan |
None |
10.1016/j.bmcl.2009.03.004 |
| Homo sapiens |
Transthyretin |
Binding affinity |
100.0 |
None |
10.1021/jm00155a010 |
| Homo sapiens |
Transthyretin |
Binding affinity |
100.0 |
None |
10.1021/jm00381a018 |
| Homo sapiens |
Transthyretin |
Concentration |
1e-08 |
M |
10.1021/jm00155a010 |
| Homo sapiens |
Transthyretin |
IC50 |
2187.76 |
nM |
10.1016/j.ejmech.2016.02.074 |
| Homo sapiens |
Transthyretin |
IC50 |
2200.0 |
nM |
10.1016/j.ejmech.2016.02.074 |
| Homo sapiens |
Transthyretin |
IC50 |
10500.0 |
nM |
10.1016/j.bmcl.2009.03.004 |
| Homo sapiens |
Transthyretin |
Inhibition |
nan |
% |
10.1016/j.ejmech.2016.02.074 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
23109.3 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
UDP-glucuronosyltransferase 1-1 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-1 |
Activity |
nan |
None |
None |
| Homo sapiens |
UDP-glucuronosyltransferase 1-1 |
IC50 |
4900.0 |
nM |
10.1124/dmd.110.035030 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-1 |
IC50 |
5600.0 |
nM |
10.1124/dmd.110.035030 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-6 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-9 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1A4 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B15 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
0.79 |
% |
10.6019/CHEMBL4513141 |
| Mus musculus |
Mus musculus |
Activity |
100.0 |
% |
10.1016/j.bmcl.2010.04.011 |
| Mus musculus |
Solute carrier organic anion transporter family member 1C1 |
Km |
0.34 |
None |
10.1210/en.2004-0058 |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b02150 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
11995.5 |
nM |
None |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
-9.42 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
17000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Bile acid transporter |
Activity |
nan |
None |
10.1006/bbrc.1998.9974 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA transporter 1 |
Inhibition |
nan |
% |
10.1021/jm5015428 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Monocarboxylate transporter 10 |
Activity |
nan |
None |
10.1074/jbc.m009462200 |
| Rattus norvegicus |
Monocarboxylate transporter 8 |
Activity |
26.0 |
% |
10.1074/jbc.m300909200 |
| Rattus norvegicus |
Monocarboxylate transporter 8 |
Activity |
69.0 |
% |
10.1074/jbc.m300909200 |
| Rattus norvegicus |
Monocarboxylate transporter 8 |
Km |
4700.0 |
nM |
10.1074/jbc.m300909200 |
| Rattus norvegicus |
Nuclear receptor subfamily 1 group I member 2 |
Activity |
nan |
None |
10.1124/dmd.110.035105 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
100.0 |
% |
10.1021/jm00227a004 |
| Rattus norvegicus |
Rattus norvegicus |
log(activity) |
2.0 |
None |
10.1021/jm00227a004 |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A1 |
Activity |
nan |
None |
10.1006/bbrc.1998.9974 |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A3 |
Activity |
nan |
None |
None |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A3 |
Km |
12000.0 |
nM |
None |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A3 |
Km |
20200.0 |
nM |
None |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A4 |
Activity |
nan |
None |
10.1074/jbc.273.35.22395 |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A4 |
Km |
6530.0 |
nM |
10.1074/jbc.273.35.22395 |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A5 |
Km |
4930.0 |
nM |
10.1074/jbc.273.35.22395 |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1B2 |
Activity |
nan |
None |
10.1016/s0014-5793(00)01596-9 |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
89125.1 |
nM |
None |
| Rattus norvegicus |
Transthyretin |
Ratio |
1.0 |
None |
10.1021/jm00384a014 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
-3.004 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
-0.15 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1758 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.14 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.05 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
5.73 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
-0.03297 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
-5.39 |
% |
10.6019/CHEMBL4513141 |
| None |
ADMET |
Binding energy |
10.3 |
kCal mol-1 |
10.1021/jm00378a021 |
| None |
ADMET |
Drug metabolism |
44.0 |
ng |
10.1021/acs.jmedchem.9b02150 |
| None |
ADMET |
Drug metabolism |
174.0 |
ng |
10.1021/acs.jmedchem.9b02150 |
| None |
ADMET |
Drug metabolism |
nan |
None |
10.1021/acs.jmedchem.9b02150 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Molecular identity unknown |
Potency |
50118.7 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Ac50 |
0.631 |
uM |
None |
| None |
Unchecked |
Ac50 |
0.7079 |
uM |
None |
| None |
Unchecked |
Ac50 |
3.981 |
uM |
None |
| None |
Unchecked |
Ac50 |
7.079 |
uM |
None |
| None |
Unchecked |
Ac50 |
7.943 |
uM |
None |
| None |
Unchecked |
Ac50 |
11.22 |
uM |
None |
| None |
Unchecked |
AC50 |
631.0 |
nM |
None |
| None |
Unchecked |
AC50 |
707.9 |
nM |
None |
| None |
Unchecked |
AC50 |
3981.1 |
nM |
None |
| None |
Unchecked |
AC50 |
7080.0 |
nM |
None |
| None |
Unchecked |
AC50 |
7943.3 |
nM |
None |
| None |
Unchecked |
AC50 |
11220.2 |
nM |
None |
| None |
Unchecked |
Activity |
12.5 |
% |
10.1021/jm00179a024 |
| None |
Unchecked |
Activity |
18.0 |
% |
10.1021/jm00179a024 |
| None |
Unchecked |
Activity |
30.0 |
% |
10.1021/jm00179a024 |
| None |
Unchecked |
Activity |
88.0 |
% |
10.1016/j.bmcl.2010.04.011 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b02150 |
| None |
Unchecked |
Hepatotoxicity (acute) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
10500.0 |
nM |
10.1021/jm401061w |
| None |
Unchecked |
Inhibition |
80.0 |
% |
10.1021/jm401061w |
| None |
Unchecked |
Potency |
31.5 |
nM |
None |
| None |
Unchecked |
Potency |
3162.3 |
nM |
None |
| None |
Unchecked |
Potency |
22296.9 |
nM |
None |